Department of Oncology

  • Finland

Publications 1991 2019

Filter
Meeting Abstract
2018

Combined Targeting of BET Family Proteins and BCL2 Is Synergistic in Acute Myeloid Leukemia Cells Overexpressing S100A8 and S100A9

Karjalainen, R., Liu, M., Kumar, A., Parsons, A., He, L., Malani, D. R., Kontro, M., Porkka, K. & Heckman, C. A., 2018, In : Blood. 132

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Open Access
2017

Characterization of Immunological Profiles with Clinical Significance in Patients with Classical Hodgkin Lymphoma

Karihtala, K., Leivonen, S-K., Karjalainen-Lindsberg, M-L. & Leppa, S., 7 Dec 2017, In : Blood. 130, 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Copanlisib (COP) in patients with relapsed or refractory indolent B-cell lymphoma: primary results of the pivotal Chronos-1 study

Dreyling, M., Santoro, A., Mollica, L., Leppa, S., Follows, G. A., Lenz, G., Kim, W. S., Nagler, A., Panayiotidis, P., Demeter, J., Ozcan, M., Kosinova, M., Bouabdallah, K., Morschhauser, F., Stevens, D. A., Trevarthen, D., Giurescu, M., Kupit, L., Childs, B. H. & Zinzani, P. L., Sep 2017, In : Oncology research and treatment. 40, p. 12-12 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Copanlisib in patients with relapsed or refractory follicular lymphoma.

Dreyling, M. H., Santoro, A., Leppa, S., Demeter, J., Follows, G., Lenz, G., Kim, W. S., Mollica, L., Nagler, A., Diong, C. P., Provencio, M., Stevens, D. A., Trevarthen, D., Magagnoli, M., Cupit, L., Yin, S., Hiemeyer, F., -Vargas, J. E. G., Childs, B. H. & Zinzani, P. L., 20 May 2017, In : Journal of Clinical Oncology. 35, 5 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses from the CHRONOS-1 study

Provencio Pulla, M., Santoro, A., Mollica, L., Leppa, S., Follows, G., Lenz, G., Kim, W. S., Nagler, A., Panayiotidis, P., Demeter, J., Ozcan, M., Kosinova, M., Bouabdallah, K., Morschhauser, F., Ishida, T., Huang, L., Garcia-Vargas, J., Childs, B. H., Zinzani, P. L. & Dreyling, M., Sep 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

EFFICACY AND SAFETY OF COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE CHRONOS-1 STUDY

Zinzani, P. L., Santoro, A., Leppa, S., Demeter, J., Follows, G. A., Lenz, G., Kim, W. S., Mollica, L., Nagler, A., Diong, C. P., Provenciio, M., Stevens, D. A., Trevarthen, D., Maagnoli, M., Cupit, L., Yin, S., Hiemeyer, F., Garcia-Vargas, J., Childs, B. H. & Dreyling, M., 26 Jun 2017, In : Haematologica. 102, p. 314-315 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Exploration of tissue morphologies in breast cancer samples using unsupervised machine learning

Turkki, R., Bychkov, D., Linder, N., Isola, J., Joensuu, H. T. & Lundin, J., 1 Jul 2017, In : Cancer Research. 77, 13 Supplement, p. 673 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

High Amount of PD-L1+Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Pollari, M., Bruck, O., Leivonen, S-K., Pellinen, T., Vahamurto, P., Karjalainen-Lindsberg, M-L., Mannisto, S., Kellokumpu-Lehtinen, P-L., Mustjoki, S. & Leppa, S., 7 Dec 2017, In : Blood. 130, Suppl 1, p. Meeting Abstract: 2761 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

Leivonen, S-K., Pollari, M., Bruck, O., Pellinen, T., Karjalainen-Lindsberg, M-L., Mannisto, S., Kellokumpu-Lehtinen, P-L., Mustjoki, S. & Leppa, S., 7 Dec 2017, In : Blood. 130, 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Th1/2 Immune Response Signature Predicts Outcome after Dose-Dense Immunochemotherapy in Patients with High Risk Diffuse Large B-Cell Lymphoma - Results from Nordic Lymphoma Group Trials

Autio, M., Leivonen, S-K., Jorgensen, J. M., Karjalainen-Lindsberg, M-L., Beiske, K., Holte, H. & Leppä, S., 7 Dec 2017, In : Blood. 130, 2 p., 4008.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2016

ASSESSMENT OF THERAPY RESPONSE IN CHRONIC MYELOID LEUKEMIA VIA 1 MONTH BCR-ABL1 TRANSCRIPT DECLINE

El Missiry, M., Hjorth-hansen, H., Richter, J., Olson-Stromberg, U., Stenke, L., Porkka, K., Kreutzmann, A. & Mustjoki, S., Jun 2016, In : Haematologica. 101, p. 63-63 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Leppa, S., Joergensen, J., Tierens, A., Ostlie, I., Fagerli, U. M., Brown, P. D. N., Larsen, T. S., Mannisto, S., Munksgaard, L., Maisenholder, M., Vasala, K., Meyer, P., Jerkeman, M., Bjorkholm, M., Fluge, O., Jyrkkio, S., Ralfkiaer, E., Spetalen, S., Karjalainen-Lindsberg, M-L. & Holte, H., 2 Dec 2016, In : Blood. 128, 22, 6 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Impact of Rituximab and Methotrexate on the Survival of the Patients with Sinonasal Tract Diffuse Large B-Cell Lymphoma

Vahamurto, P., Mannisto, S., Pollari, M., Karjalainen-Lindsberg, M-L., Makitie, A. A. & Leppa, S., 2 Dec 2016, In : Blood. 128, 22, 6 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups

Zhang, J., Reddy, A., Love, C., Moffitt, A. B., Rajagopalan, D., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M-L., Norgaard, P. H., Pederson, M., Gang, A. O., Hogdall, E., Richards, K. L., Fedoriw, Y. D., Bernal-Mizrachi, L., Koff, J. L., Staton, A. D., Flowers, C., Paltiel-Clarfield, O. & 23 othersGoldschmidt, N., Calaminici, M., Clear, A. J., Gribben, J., Nguyen, E., Czader, M., Ondrejka, S. L., Collie, A., Hsi, E. D., Au-Yeung, R., Yok-Lam, K., Choi, W. L., Srivastava, G., Evens, A. M., Pilichowska, M., Sengar, M., Reddy, N., Li, S., Jaffe, E. S., Tzeng, T., Datta, J., Dunson, D. & Dave, S., 2 Dec 2016, In : Blood. 128, 22, 6 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study

Davies, A. J., Mihaljevic, B., Mercadal, S., Mihaylov, G., Leppa, S., Cotting, D., Veenstra, K., Zharkov, A., Dixon, M., Barrett, M. & Macdonald, D., 2 Dec 2016, In : Blood. 128, 22, 6 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Low Expression and Somatic Mutations of the KLHL6 Gene Predict Poor Survival in Patients with Activated B-Cell like Diffuse Large B-Cell Lymphoma

Meriranta, L., Pasanen, A., Cervera, A., Holte, H., Lehtonen, R., Hautaniemi, S. & Leppa, S., 2 Dec 2016, In : Blood. 128, 22, 4 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Low Expression of the CIITA Gene Predicts Poor Outcome in Diffuse Large B-Cell Lymphoma

Autio, M., Jantti, K., Cervera, A., Hautaniemi, S. & Leppa, S., 2 Dec 2016, In : Blood. 128, 22, 3 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Mutational Landscape of Aggressive Natural Killer Cell Leukemia and Drug Sensitivity Profiling Reveal Therapeutic Options in Natural Killer Cell Malignancies

Dufva, O., Kankainen, M., Kelkka, T., Awad, S. A., Sekiguchi, N., Yadav, B., Eldfors, S., Kuusanmaki, H., Andersson, E. I., Malani, D., Pietarinen, P., Saikko, L., Kovanen, P. E., Suzumiya, J., Suzuki, R., Ko, Y. H., Kim, W. S., Chuang, S-S., Loughran, T. P., Chan, W. C. & 4 othersOhshima, K., Aittokallio, T., Ishida, F. & Mustjoki, S., 2 Dec 2016, In : Blood. 128, 22, 4 p., 2921.

Research output: Contribution to journalMeeting AbstractResearch

SOMATIC MUTATIONS IN CLONALLY EXPANDED CD8(+) T CELLS IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS

Kelkka, T., Savola, P., Rajala, H., Kuuliala, A., Kuuliala, K., Eldfors, S., Ellonen, P., Lagstrom, S., Khajuria, R. K., Jaatinen, T., Koivuniemi, R., Repo, H., Saarela, J., Porkka, K., Leirisalo-Repo, M. & Mustjoki, S., Feb 2016, In : Annals of the Rheumatic Diseases. 75, p. A47-+ 2 p.

Research output: Contribution to journalMeeting AbstractResearch

The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

Clausen, M. R., Leppa, S., Brown, P. D. N., Goerloev, J. S., Panny, M., Willenbacher, W., Sillesen, I. B., Segel, E., Bentzen, H., Thorsgaard, M., Pulczynski, E. J., Kamper, P., Gormsen, L. C., Mortensen, J., Lauritzsen, G., Relander, T. & d'Amore, F., 2 Dec 2016, In : Blood. 128, 22, 4 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2015

COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS RITUXIMAB IN THE MAINTENANCE SETTING: UPDATED SAFETY RESULTS OF THE PHASE III SABRINA STUDY IN PATIENTS WITH FOLLICULAR LYMPHOMA

Davies, A., Mihaljevic, B., Mercadal, S., Mihaylov, G., Leppa, S., Cotting, D., Munoz, F. J., Veenstra, K., Berthillon, N., Barrett, M. & MacDonald, D., Jun 2015, In : Haematologica. 100, p. 271-272 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone (Pix), etoposide, and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-Hodgkin lymphomas (aNHL)

d'Amore, F., Jorgensen, J., Sillesen, I., Segel, E., Bentzen, H., Thorsgaard, M., Pulczinsky, E. J., Pedersen, B. B., Gillstroem, D., Clausen, M., Kamper, P., Silkjaer, T., Gormsen, L., Leppa, S., Toldbod, H. E., Turton, M., Zintl, P. & Theocharous, P., Apr 2015, In : British Journal of Haematology. 169, p. 65-65 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2014

Characterization of the Microrna Expression Profiles of Paired Primary and Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) By Next-Generation Sequencing

Leivonen, S-K., Icay, K., Liu, C., Taskinen, M., Lehtonen, R., Karjalainen-Lindsberg, M-L., Delabie, J., Holte, H., Hautaniemi, S. & Leppa, S., 6 Dec 2014, In : Blood. 124, 21, 3 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

COMBINING SEVERAL MOLECULAR ABNORMALITIES IN IDENTIFICATION OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA IMPROVES RISK-STRATIFICATION

Fiskvik, I., Delabie, J., Beiske, K., Leppa, S., Eriksson, M., Smeland, E. & Holte, H., 1 Jun 2014, In : Haematologica. 99, p. 413-414 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Identification of Novel Germline Variants in Early-Onset Familial Classical Hodgkin Lymphoma with Exome Sequencing

Kilpivaara, O., Ristolainen, H., Kamper, P., Taskinen, M., Saarinen, S., Leppa, S., d'Amore, F. & Lauri, A. A., 6 Dec 2014, In : Blood. 124, 21, p. 4402 3 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Plasma Affinity Proteomic Immunoprofiling As a Novel Prognostic Tool in High Risk Diffuse Large B-Cell Lymphoma Patients: A Nordic Lymphoma Group Study

Fjorden, K., Pauly, F., Leppa, S., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Eriksson, M., Isinger-Ekstrand, A., Borrebaeck, C., Jerkeman, M. & Wingren, C., 6 Dec 2014, In : Blood. 124, 21, 3 p., 1618.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas

d'Amore, F., Joergensen, J., Sillesen, I. B., Segel, E., Bentzen, H., Thorsgaard, M., Pulczynski, E. J., Pedersen, B. B., Gillstrom, D., Clausen, M., Kamper, P., Silkjaer, T., Gormsen, L. C., Leppa, S. & Toldbod, H., 6 Dec 2014, In : Blood. 124, 21, 4 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

RETROSPECTIVE ANALYSIS OF PRIMARY CHEMOIMMUNOTHERAPY WITH BENDAMUSTINE IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH INDOLENT AND MANTLE-CELL LYMPHOMAS

Hagberg, H., Hogberg, K., Jensen, B. A., Leppa, S., Munksgaard, L. & Szatkowski, D., 1 Jun 2014, In : Haematologica. 99, p. 692-692 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Somatic Mutations in E3 Ubiquitin Ligase Deltex 1 Are Associated with Survival in Diffuse Large B-Cell Lymphoma

Taskinen, M., Meriranta, L., Pasanen, A., Louhimo, R., Cervera, A., Karjalainen-Lindsberg, M-L., Holte, H., Delabie, J., Lehtonen, R., Hautaniemi, S. & Leppa, S., 6 Dec 2014, In : Blood. 124, 21, 3 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2013

Frequent Activating Mutations Of JAK-STAT Pathway Genes In Natural Killer Cell Lymphomas

Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, L. M., Iqbal, J., Zhang, W., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H., d'Amore, F., Leppa, S., Liu, W., McKeithan, T. & Chan, W. C., 15 Nov 2013, In : Blood. 122, 21, 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Global Profiling Of Outcome Associated Alternative Splicing Events and Gene Expression In Diffuse Large B-Cell Lymphoma

Taskinen, M., Chen, P., Karjalainen-Lindsberg, M-L., Cervera, A., Delabie, J., Holte, H., Hautaniemi, S. & Leppae, S., 15 Nov 2013, In : Blood. 122, 21, 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

High-throughput drug screening and molecular profiling for therapeutic targeting of NUP98-NSD1-positive AML

Kontro, M. P., Pemovska, T., Heckman, C. A., Kallioniemi, O-P., Wennerberg, J. K. & Porkka, K. V. K., Feb 2013, In : Annals of Hematology. 92, Supplement 1, p. S18

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

Salles, G. A., Seymour, J. F., Feugier, P., Offner, F., Lopez-Guillermo, A., Belada, D., Xerri, L., Bouabdallah, R., Catalano, J., Pauline, B., Caballero, D., Haioun, C., Pedersen, L. M., Delmer, A., Simpson, D., Leppa, S., Soubeyran, P., Hagenbeek, A., Casasnovas, O., Intragumtornchai, T. & 9 othersFerme, C., da Silva, M. G., Sebban, C., Lister, A., Estell, J. A., Milone, G., Sonet, A., Coiffier, B. & Tilly, N., 15 Nov 2013, In : Blood. 122, 21, 3 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2012

Alternative Splicing and Expression of Class II Tubulin Beta (TUBB2B) Are Associated with Outcome in Diffuse Large B-Cell Lymphoma

Taskinen, M., Koivula, S., Chen, P., Karjalainen-Lindsberg, M-L., Cervera, A., Delabie, J., Holte, H., Hautaniemi, S. & Leppa, S., 16 Nov 2012, In : Blood. 120, 21, 2 p., Meeting Abstract: 1557.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Autologous stem cell transplantation for follicular lymphoma: a nation-wide survey with a very long follow-up

Jantunen, E., Juvonen, E., Lehtinen, T., Kuittinen, O., Itala-Remes, M., Wiklund, T., Elonen, E., Nousiainen, T. & Leppa, S., Apr 2012, In : Bone Marrow Transplantation. 47, p. S455-S456 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

d'Amore, F., Leppa, S., da Silva, M. C., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, G. F., Pezzutto, A., Van Hoof, A., van Gelder, M., Doorduijn, J. K., Wu, K. L., Kluin-Nelemans, J. C., Lugtenburg, P. J., Jankovska, M., Merup, M., Fagerli, U-M., Walewski, J., Hagberg, H., Mariz, J. M. & 26 othersHansen, P. B., Noesslinger, T., Janssens, A., Brandefors, L., Demuynck, H., Schaafsma, M. R., Christiansen, I., Salek, D., Jyrkkio, S., Prochazka, V., Zijlstra, J., Bohmer, L., Greil, R., Stevens, W., Fijnheer, R., Kooy, M. V. M., Grube, M., Hopfinger, G., Van den Neste, E., Jantunen, E., Truemper, L., Wulf, G., Altmann, B., Ziepert, M., Loeffler, M. & Toldbod, H., 16 Nov 2012, In : Blood. 120, 21, 3 p., Meeting Abstract: 57.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma

Leppa, S., Taskinen, M., Koivula, S., Chen, P., Louhimo, R., Delabie, J., Karjalainen-Lindsberg, M-L., Bjorkholm, M., Fluge, O., Pedersen, L. M., Rydstrom, K., Jerkeman, M., Eriksson, M., Hautaniemi, S., Holte, H. & Nordic Lymphoma Grp, 20 May 2012, In : Journal of Clinical Oncology. 30, 15, 1 p., Meeting Abstract: 8074.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2011

(18)FDG PET/CT AFTER INTENSIFIED CHEMO-IMMUNOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AGED 18-65 YEARS WITH AAIPI 2-3. POSITIVE OR INDETERMINATE LESIONS HAVE A LOW POSITIVE PREDICTIVE VALUE. A NORDIC PHASE II SUBSTUDY

Holte, H., Bogsrud, T., Leppa, S., Laukka, M., Bjorkholm, M., Jacobsson, H., Jyrkkio, S., Seppanen, M., Jerkeman, M., Brun, E., Fluge, O. & Pedersen, L. M., Jun 2011, In : Annals of Oncology. 22, p. 159-159 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Addition of Rituximab to Chemotherapy Alters the Prognostic Impact of Tumor-Associated Macrophages in Diffuse Large B-Cell Lymphoma

Riihijarvi, S., Poyhonen, M., Taskinen, M., Karjalainen-Lindsberg, M-L. & Leppa, S., 18 Nov 2011, In : Blood. 118, 21, p. 1139-1139 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Age-Adjusted Combined Immunochemotherapy without Radiotherapy in Newly Diagnosed PCNSL - A Phase II Trial of the Nordic Lymphoma Group

Pulczynski, E. J., Kamper, P., Fagerli, U-M., Erlanson, M., Kuittinen, O., Fossa, A., Ostenstad, B., Fluge, O., Maisenholder, M., Hagberg, H., Eriksson, M., Nordstrom, M. & Leppa, S., 18 Nov 2011, In : Blood. 118, 21, p. 696-696 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

ALEMTUZUMAB DOES NOT AFFECT HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN T-CELL LYMPHOMA: DATA FROM THE ACT-1 TRIAL

Lauritzsen, G. F., Da Silva, M. G., Leppa, S., Pezzutto, A., Relander, T., Weidmann, E., Van Gelder, M., Doorduijn, J., Hansen, P., Altmann, B., Toldbod, H. & D'Amore, F., Jun 2011, In : Annals of Oncology. 22, suppl 4, p. 232-232 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Clinicopathological Differences Between Asian and Western Patients with De Novo Diffuse Large B Cell Lymphoma Treated with R-CHOP

Sinclair, N., Beltran, B. E., Song, M-K., Ilic, I., Leppa, S., Nyman, H., Uccella, S., Seki, R., Li, J., Treaba, D. O., Butera, J. N. & Castillo, J. J., 18 Nov 2011, In : Blood. 118, 21, p. 1144-1145 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

d'Amore, F., da Silva, M. G., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, G. F., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, U-M., Brown, P. D. N., Hansen, P. B., Mariz, J. M., Jankovska, M., Walewski, J., Doorduijn, J., Van Hoof, A., Christiansen, I., Jyrkkio, S. & 20 othersKluin-Nelemans, J. C., Kooy, M. V. M., Fijnheer, R., Stevens, W., Zijlstra, J., Bohmer, L., Lugtenburg, P. J., Grube, M., Prochazka, V., Salek, D., Greil, R., Trumper, L., Wulf, G., Altmann, B., Ziepert, M., Loeffler, M., Jantunen, E., Hopfinger, G., Van den Neste, E. & Toldbod, H., 18 Nov 2011, In : Blood. 118, 21, p. 1755-1755 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

INTEGRATIVE GENOMIC PROFILING OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS LESS THAN 65 YEARS OLD TREATED WITH DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS

Koivula, S., Taskinen, M., Louhimo, R., Chen, P., Delabie, J., Holte, H., Karjalainen-Lindsberg, M., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S. & Leppa, S., Jun 2011, In : Annals of Oncology. 22, p. 207-207 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

PROGNOSTIC IMPACT OF TUMOR-ASSOCIATED MACROPHAGES ON SURVIVAL OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY SUPPORTED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION

Poyhonen, M., Taskinen, M., Karjalainen-Lindsberg, M., Jantunen, E., Kosma, V. & Leppa, S., Jun 2011, In : Annals of Oncology. 22, p. 145-146 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

2010

Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Karjalainen-Lindsberg, M-L., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S. & Leppa, S., 19 Nov 2010, In : Blood. 116, 21, p. 1281-1281 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years

Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M-L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Pedersen, L. M., Anderson, H., Jerkeman, M. & Eriksson, M., 19 Nov 2010, In : Blood. 116, 21, p. 1157-1157 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

RITUXIMAB MAINTENANCE FOR 2-YEARS SIGNIFICANTLY IMPROVES THE OUTCOME OF PATIENTS WITH UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA AFTER RESPONSE TO IMMUNOCHEMOTHERAPY: RESULTS OF THE PRIMA STUDY

Salles, G., Catalano, J., Feugier, P., Offner, F., Bouabdallah, R., Caballero, D., Brice, P., Pedersen, L. M., Haioun, C., Belada, D., Delmer, A., Simpson, D., Tilly, H., Leppa, S., Soubeyran, P., Hagenbeek, A., Casasnovas, O., Tanin, I., Ferme, C., Gomes Da Silva, M. & 8 othersSebban, C., Pettengell, R., Estell, J., Milone, G., Sonnet, A., Lopez-Guillermo, A., Seymour, J. & Xerri, L., Jun 2010, In : Haematologica. 95, p. 229-229 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)

d'Amore, F., da Silva, M. G., Leppa, S., Pezzutto, A., Relander, T., Lauritzsen, G. F., Weidmann, E., Van Gelder, M., Doorduijn, J., Kluin-Nelemans, J. C., Kooy, M. V. M., Fijnheer, R., de Weerdt, O., Brown, P. D. N., Hansen, P. B., Merup, M., Grube, M., Mariz, J. M., Walewski, J., Truemper, L. & 4 othersWulf, G., Jantunen, E., Hopfinger, G. & Prochazka, V., 19 Nov 2010, In : Blood. 116, 21, p. 992-993 2 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Castillo, J. J., Beltran, B., Chung, J-S., Ilic, I., Leppa, S., Seki, R., Uccella, S., Xia, Z-G. & Butera, J. N., 19 Nov 2010, In : Blood. 116, 21, p. 1679-1679 1 p.

Research output: Contribution to journalMeeting AbstractResearchpeer-review